Review
Oct 2026
Current perspectives in the pharmacological combination treatment for low-grade serous ovarian cancer.
INTRODUCTION Low-grade serous ovarian carcinoma (LGSOC) is a rare, frequently relapsing ovarian cancer characterized by relative chemoresistance, hormone-receptor expression, and recurrent activation of the RAS/RAF/MEK/ERK pathway. AREAS COVERED This narrative review examines the therapeutic vulnerabilities that are...
O. De Tommasi, Namrata Sethi, Stefania Bellone et al.
· Expert Opinion on Pharmacoth... · 0 citations